United Therapeutics Corp. operates as a biotechnology ... cardiovascular and infectious diseases and cancer. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered ...

Founded in 1996 with a focus on treating rare diseases, United Therapeutics (NASDAQ:UTHR) is a biotechnology company focused on developing and commercializing innovative therapies for rare ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ:UTHR) develops and commercializes medications for chronic lung diseases and ...

On average, they are down 15.4% since the latest earnings results. Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ:UTHR) develops ...

United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.